Comet Therapeutics

About:

Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.

Website: https://comettherapeutics.com/

Twitter/X: comettx1

Top Investors: Sofinnova Partners, Mission BioCapital, Canaan Partners, Inkef

Description:

CoEnzyme is a developer of therapies designed to treat orphan neurological disorders. The company develops a treatment to restore dysregulated CoEnzyme A metabolism through its CoEnzyme metabolism platform, enabling physicians to address the profound unmet medical needs.

Total Funding Amount:

$28.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Founders:

Enej Kuscer

Number of Employees:

1-10

Last Funding Date:

2019-06-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai